According to filings released on September 24, 2026, several Hong Kong-listed companies have reported updates to their shareholding structures. The disclosures involve Shijiazhuang Yiling Pharmaceutical Co Ltd (02005), Gu Sheng Tang (02273), and ZTO Express (Cayman) Inc (02057).

Qu Jiguang increased his long position in Shijiazhuang Yiling Pharmaceutical Co Ltd (02005) from 1.278 billion shares to 1.279 billion shares. This move adjusts his holding ratio to 43.35%, up from the previously recorded 43.31%.

Tu Zhiliang raised his stake in Gu Sheng Tang (02273) from 82.2022 million shares to 82.2122 million shares. His shareholding percentage now stands at 35.08%, compared to 35.07% in the prior filing.

China Pharmaceutical Company Limited also increased its holding in Shijiazhuang Yiling Pharmaceutical Co Ltd (02005), moving from 921 million shares to 923 million shares. The latest ownership ratio is 31.26%, up from the previous 31.22%.

Several entities affiliated with Alibaba reduced their long positions in ZTO Express (Cayman) Inc (02057). Taobao Holding Limited cut its stake from 61.1924 million shares to 37.8012 million shares, lowering its ownership from 10.98% to 6.78%. Similarly, Taobao China Holding Limited reduced its holding from 61.1924 million shares to 37.8012 million shares, with its ratio dropping to 6.78% from 10.98%.

Alibaba ZT Investment Limited trimmed its position in ZTO Express (Cayman) Inc (02057) from 57.8704 million shares to 34.4792 million shares, resulting in a decrease in ownership percentage from 10.38% to 6.19%. Meanwhile, Alibaba Group Holding Limited lowered its stake from 71.9413 million shares to 46.9413 million shares, reducing its ratio from 12.91% to 8.42%.

Note: Fluctuations in share counts may result from corporate actions such as rights issues, share consolidations, or share splits. Investors are advised to cross-reference these figures with actual market conditions for accurate interpretation.